National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

therapeutic tumor infiltrating lymphocytes
A preparation of cells, consisting of autologous tumor infiltrating lymphocytes, that are manipulated in vitro and, upon administration in vivo, re-infiltrate the tumor to initiate tumor cell lysis. In vitro, therapeutic tumor-infiltrating lymphocytes (TILs) are isolated from tumor tissue and cultured with lymphokines such as interleukin-2; the therapeutic TILs are then infused into the patient, where, after re-infiltration of the tumor, they may induce lysis of tumor cells and tumor regression. The use of therapeutic TILs is considered a form of adoptive immunotherapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:tumor infiltrating lymphocytes



Previous:therapeutic immune globulin, therapeutic melatonin, therapeutic progesterone, therapeutic testosterone, therapeutic triiodothyronine
Next:TheraSphere, ThermoDox, thiabendazole, thiamine, Thibenzole

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov